Ultra Bone-Up

Suggested/Recommended/Usage/Directions

Usage: Take 2 tablets 3 times per day (for a total of 6) with meals to facilitate maximum absorption, or as directed by your qualified healthcare professional.

Precautions re: Pregnant or Nursing or Prescription Medications

Note: If you have a medical condition, are pregnant, lactating, trying to conceive, or taking medications (especially warfarin/Coumadin), consult your healthcare professional before using this product.

Formula re: Contains

Ultra Bone-Up is an ultra bone-health system that provides StimuCal MicroCrystalline HydroxyApatite (MCHA) and micronutrients for bone health. StimuCal MCHA is a natural source of calcium levels in the blood with supplementation. StimuCal also provides bone proteins, including type I collagen, which has been shown in clinical research to support bone health. Vitamin D3 and K2 (as natural MK-7 from fermentation) work together to enhance calcium deposition into bones. Ultra Bone-Up also includes JarroSil Activated Silicon for ultra support. Increased intake of bioavailable silicon supports bone mineral density and strength.

Formulation re: Other

Health Claim: Adequate calcium and vitamin D as part of a healthful diet, along with physical activity, may reduce the risk of osteoporosis later in life.

Precautions re: Children

Keep out of the reach of children.

Storage

Store in a cool, dry place.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Brand IP Statement(s) re: (c), (TM), (SM)

2020 Jarrow Formulas

Formulation re: Other

Ultra bone-health system

Formula re: Contains

Enhanced formula with: More MK-7 for increased bone support Bioavailable silicon for bone density & strength

FDA Statement of Identity

Dietary Supplement

Formulation re: Does NOT Contain

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.

Brand IP Statement(s) re: (c), (TM), (SM)

StimuCal is a registered trademark of PharmaZen Ltd., and is patent pending. JarroSil is protected under U.S. Patent # 8,563,072 B2.